Abstract
Ginsenosides, the major bioactive compounds in ginseng root, have been found to have antioxidant, immunomodulatory, and anti-inflammatory activities. In the present study, we sought to investigate whether and how ginsenoside Rb1 (GS-Rb1), the most abundant ginsenoside, can protect blood–brain barrier (BBB) integrity following cerebral ischemia in middle cerebral artery occlusion (MCAO) animal model. ICR mice underwent MCAO and received GS-Rb1 by intraperitoneal injection at 3 h after reperfusion. We evaluated infarction, neurological scores, brain edema, Evans blue (EB) extravasation, and tight junction protein expression at 48 h after MCAO. We further examined whether GS-Rb1 protected BBB integrity by suppressing post-ischemic inflammation-induced activity of matrix metalloproteinase-9 (MMP-9) and nicotinamide adenine dinucleotide phosphate oxidase (NOX). First, GS-Rb1 decreased infarction and improved neurological deficits in MCAO animals. In addition, GS-Rb1 reduced EB extravasation and brain edema and preserved expression of tight junction proteins in the ischemic brain. Moreover, GS-Rb1 inhibited expression of pro-inflammatory factors including nitric oxide synthase and IL-1β, but increased expression of anti-inflammatory markers arginase 1 and IL-10 in the ischemic brain. Consistently, GS-Rb1 attenuated ischemia-induced expression and activity of MMP9. Finally, GS-Rb1 reduced NOX-4 mRNA expression and NOX activity in ischemic brain. These results suggest that GS-Rb1 protects loss of BBB integrity in ischemic stroke by suppressing neuroinflammation induction of MMP-9 and NOX4-derived free radicals, and indicate its potential for treating brain injuries, such as ischemia and stroke.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245–313. doi:10.1152/physrev.00044.2005
Bolton SJ, Anthony DC, Perry VH (1998) Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo. Neuroscience 86:1245–1257
Candelario-Jalil E, Taheri S, Yang Y et al (2007) Cyclooxygenase inhibition limits blood–brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat. J Pharmacol Exp Ther 323:488–498. doi:10.1124/jpet.107.127035
Chang DI, Hosomi N, Lucero J, Heo JH, Abumiya T, Mazar AP, del Zoppo GJ (2003) Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia. J Cereb Blood Flow Metab 23:1408–1419. doi:10.1097/01.WCB.0000091765.61714.30
Chen JW, Breckwoldt MO, Aikawa E, Chiang G, Weissleder R (2008) Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain 131:1123–1133. doi:10.1093/brain/awn004
Cho YL, Hur SM, Kim JY et al (2015) Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation. J Biol Chem 290:467–477. doi:10.1074/jbc.M114.603142
Christensen LP (2009) Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 55:1–99. doi:10.1016/S1043-4526(08)00401-4
Fleegal MA, Hom S, Borg LK, Davis TP (2005) Activation of PKC modulates blood–brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. Am J Physiol Heart Circ Physiol 289:H2012–H2019. doi:10.1152/ajpheart.00495.2005
Heo JH, Han SW, Lee SK (2005) Free radicals as triggers of brain edema formation after stroke. Free Radic Biol Med 39:51–70. doi:10.1016/j.freeradbiomed.2005.03.035
Hou YL, Tsai YH, Lin YH, Chao JC (2014) Ginseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in rats. BMC Complement Altern Med 14:415. doi:10.1186/1472-6882-14-415
Hu X, Li P, Guo Y et al (2012) Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43:3063–3070. doi:10.1161/STROKEAHA.112.659656
Huang J, Upadhyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66:232–245. doi:10.1016/j.surneu.2005.12.028
Huang J, Li Y, Tang Y, Tang G, Yang GY, Wang Y (2013) CXCR4 antagonist AMD3100 protects blood–brain barrier integrity and reduces inflammatory response after focal ischemia in mice. Stroke 44:190–197. doi:10.1161/STROKEAHA.112.670299
Infanger DW, Sharma RV, Davisson RL (2006) NADPH oxidases of the brain: distribution, regulation, and function. Antioxid Redox Signal 8:1583–1596. doi:10.1089/ars.2006.8.1583
Kim YC, Kim SR, Markelonis GJ, Oh TH (1998) Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. J Neurosci Res 53:426–432
Kim KA, Jung IH, Park SH, Ahn YT, Huh CS, Kim DH (2013) Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K. PLoS ONE 8:e62409. doi:10.1371/journal.pone.0062409
Kimura Y, Sumiyoshi M, Sakanaka M (2012) Effects of ginsenoside Rb(1) on skin changes. J Biomed Biotechnol 2012:946242. doi:10.1155/2012/946242
Lehner C, Gehwolf R, Tempfer H, Krizbai I, Hennig B, Bauer HC, Bauer H (2011) Oxidative stress and blood–brain barrier dysfunction under particular consideration of matrix metalloproteinases. Antioxid Redox Signal 15:1305–1323. doi:10.1089/ars.2011.3923
Li J, Zhong W, Wang W et al (2014) Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation. PLoS ONE 9:e87810. doi:10.1371/journal.pone.0087810
Liu ZQ, Luo XY, Liu GZ, Chen YP, Wang ZC, Sun YX (2003) In vitro study of the relationship between the structure of ginsenoside and its antioxidative or prooxidative activity in free radical induced hemolysis of human erythrocytes. J Agric Food Chem 51:2555–2558. doi:10.1021/jf026228i
Liu W, Sood R, Chen Q et al (2008) Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke. J Neurochem 107:1196–1205. doi:10.1111/j.1471-4159.2008.05664.x
Meyers PM, Schumacher HC, Connolly ES Jr, Heyer EJ, Gray WA, Higashida RT (2011) Current status of endovascular stroke treatment. Circulation 123:2591–2601. doi:10.1161/CIRCULATIONAHA.110.971564
Montaner J, Alvarez-Sabin J, Molina C et al (2001a) Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 32:1759–1766
Montaner J, Alvarez-Sabin J, Molina CA, Angles A, Abilleira S, Arenillas J, Monasterio J (2001b) Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 32:2762–2767
Moroni F, Chiarugi A (2009) Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment. FEBS J 276:36–45. doi:10.1111/j.1742-4658.2008.06768.x
Peters S, Cree IA, Alexander R et al (2007) Angiopoietin modulation of vascular endothelial growth factor: effects on retinal endothelial cell permeability. Cytokine 40:144–150. doi:10.1016/j.cyto.2007.09.001
Rosenberg GA, Yang Y (2007) Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg Focus 22:E4
Sandoval KE, Witt KA (2008) Blood–brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32:200–219. doi:10.1016/j.nbd.2008.08.005
Schreibelt G, Kooij G, Reijerkerk A et al (2007) Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 21:3666–3676. doi:10.1096/fj.07-8329com
Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, Turner JR (2006) Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119:2095–2106. doi:10.1242/jcs.02915
Siddique MS, Eddeb F, Mantle D, Mendelow AD (2000) Extracts of Ginkgo biloba and Panax ginseng protect brain proteins from free radical induced oxidative damage in vitro. Acta Neurochir Suppl 76:87–90
Uchida M, Palmateer JM, Herson PS, DeVries AC, Cheng J, Hurn PD (2009) Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice. J Cereb Blood Flow Metab 29:1454–1462. doi:10.1038/jcbfm.2009.60
Wang Y, Jia J, Ao G et al (2014) Hydrogen sulfide protects blood–brain barrier integrity following cerebral ischemia. J Neurochem 129:827–838. doi:10.1111/jnc.12695
Weis SM, Cheresh DA (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437:497–504. doi:10.1038/nature03987
Wu Y, Yu Y, Szabo A, Han M, Huang XF (2014) Central inflammation and leptin resistance are attenuated by ginsenoside Rb1 treatment in obese mice fed a high-fat diet. PLoS ONE 9:e92618. doi:10.1371/journal.pone.0092618
Zhou Y, Li HQ, Lu L, Fu DL, Liu AJ, Li JH, Zheng GQ (2014) Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression. Phytomedicine 21:998–1003. doi:10.1016/j.phymed.2013.12.005
Zhu W, Wang L, Zhang L et al (2010) Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice. Neuroscience 169:758–769. doi:10.1016/j.neuroscience.2010.05.038
Zhu J, Jiang Y, Wu L, Lu T, Xu G, Liu X (2012) Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia. Neuroscience 202:342–351. doi:10.1016/j.neuroscience.2011.11.070
Acknowledgments
This work was supported by The Heath Planning Commission Project of Pu Dong New Area, Shanghai (No. PKJ2012-Y3) and The Heath Planning Commission Project of Pu Dong New Area (No. PWZz-2013-13).
Ethical standards
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chen, W., Guo, Y., Yang, W. et al. Protective effect of ginsenoside Rb1 on integrity of blood–brain barrier following cerebral ischemia. Exp Brain Res 233, 2823–2831 (2015). https://doi.org/10.1007/s00221-015-4352-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00221-015-4352-3